Skip to content

Prospective Study of Minimally Invasive (Laparoscopic and Robotic) Hernia Repair (Incisional and Primary, Midline and Lateral, Not Inguinal)

Prospective Study of Minimally Invasive Hernia Repair

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07544238
Acronym
PROMISER
Enrollment
400
Registered
2026-04-22
Start date
2026-04-14
Completion date
2036-04-14
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia Lumbar, Incisional Hernia Repair, Ventral Hernia Midline

Brief summary

The participating researchers register all adult patients (who have given informed written consent) scheduled for elective repair of an abdominal wall hernia (NOT inguinal hernias) via minimally invasive operation technique (i.e.: laparoscopy or robotic repair) and perform a follow up of 5 years to analyze clinical outcome parameters. These parameters include recurrence of the hernia, intra- and postoperative complications, quality of live, esthetic outcome and pain. The patients will be reviewed in person by the participating researchers at 2-3 moths, 1 year, 3 years and 5 years after surgery. A computed tomography will be performed at 1 year after surgery and in case of suspicion of complications, for example hernia recurrence. The treatment and follow-up of the participating patients does not differ from the standard treatment protocol (and the not participating patients).

Interventions

PROCEDUREMinimally invasive hernioplastia

laparoscopic or robotically assisted hernioplastia

Sponsors

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for elective minimally invasive ventral hernia repair due to criteria of the participating surgeons

Exclusion criteria

* Patient rejects participation or giving written informed consent * Positive pregnancy test (Beta HCG in serum) * Patients who do not meet criteria for minimally invasive surgery due to the criteria of the including surgeon or anesthesiologist (Loss of domain, giant abdominal wall herniae, very small (W1) isolated midline hernia, severe pulmonary or cardiac pathologies)

Design outcomes

Primary

MeasureTime frameDescription
Hernia recurrence rate5 years (the time to recurrence will be defined by the moment of radiological confirmation)Percentage of all the patients intervened who present a radiologically (via CAT Scan or MRI in case of contraindication for CAT Scan) confirmed hernia recurrence. In case of suspicion (physical exam and/or symptoms reported by the patient) a CAT Scan will be performed to confirm or discard the diagnosis, at any time of the follow-up

Secondary

MeasureTime frameDescription
Postoperative complications Clavien Dindo90 days after surgeryRegistration of postoperative complications according to the Clavien Dindo Definition
Surgical Site Occurrence (SSO)5 yearsAny alteration of postoperative wound healing (including surgical site infection, hematoma, seroma and wound dehiscence) and the required intervention (none, bedside intervention, radiologically guided intervention, surgery)
Perioperative bleeding30 daysAny drop in serum hemoglobin levels \> 2 g/dl within 24 hours or \> 3 g/dl compared to preoperative values or hemodynamically relevant bleeding or necessity for blood transfusion or surgical reintervention because of bleeding
Mortality5 yearsPercentage of the total of registered patients who perish
Hernia associated quality of life5 yearsHernia associated quality of life assessed by the EuraHS QoL (European Registry for Abdominal Wall Hernias Quality of Life Questionnaire). The questionnaire contemplates 9 items, scoring them with values of 0-10. They are subgroups into 3 items assessing pain, 4 items assessing restriction of activities and 2 items assessing the cosmetic outcome as perceived by the patient. A higher score means is linked to a worse outcome. 0 points would be the best outcome, 90 points the worst outcome possible.
Postoperative pain24 and 48 hours after surgery (during the rest of the follow-up this value is included in the EuraHS QoL questionnaire)Postoperative pain measured via VAS (Visual Analogue Scale, valued with 0-10 points, lower numbers relating to less pain, higher numbers to more pain, that is: a worse outcome)
Reintervention Rate5 yearsPercentage of the total of registered patients with surgical reintervention due to complications of the performed surgery (hernia recurrence or others)
Risk FactorsOnly at time of inclusionDescrition of the incidence of known risk factors for hernia formation at the time of surgery (Diabetes mellitus, arterial hypertension, dislipemia, anti aggregation, anticoagulation, pathologies of the connective tissues like Ehlers-Danlos or Marfan syndrome, abdominal aortic ectasia or aneurysm, cardiac pathologies, active malignant disease, chemotherapy within the last 3 months, active smoking, alcohol abuse, chronic liver disease
Prehabilitationat the time of registrationDescription of the percentage of patients treated with either Botox injection into the abdominal wall within 8 weeks before surgery and / or pulmonary prehabilitation and / or included in a weight loss program before surgery and / or have canceled an existing smoking habit before surgery

Countries

Spain

Contacts

CONTACTMarius Kaeser, Doctors Degree
marius.kaser@quironsalud.es0034 915 50 48 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026